Amanote Research
Register
Sign In
Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Chronic Lymphocytic Leukemia（CLL）Patients in China
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.07.829
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
September 1, 2018
Authors
S Zhu
L Tao
J Wang
L Du
D Xiao
Y Zhang
J Xuan
Publisher
Elsevier BV
Related search
DNA Methylation Profiles in Chronic Lymphocytic Leukemia Patients Treated With Chemoimmunotherapy
Clinical Epigenetics
Genetics
Developmental Biology
Molecular Biology
DNA Methylation Signatures in Chronic Lymphocytic Leukemia (CLL)
Science-Business eXchange
Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).
International Journal of Advanced Research
Consolidation Treatment With Lenalidomide Following Front-Line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Still a Role for Second-Line Chemoimmunotherapy in Chronic Lymphocytic Leukemia?
Haematologica
Hematology
Chronic Lymphocytic Leukemia: A Review of Front-Line Treatment Options, With a Focus on Elderly CLL Patients
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Myocardial Contractility Dysfunction in Patients With Chronic Lymphocytic Leukemia Receiving Chemotherapy and Their Treatment With Enalapril
Russian Journal of Cardiology
Cardiovascular Medicine
Cardiology
